Clinical Trial Update: Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating EN001 for Duchenne Muscular Dystrophy across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• EN001

Snippet

Sponsor: ENCell | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: UNKNOWN